Trimethylamine-N-Oxide: A Carnitine-Derived Metabolite That Prolongs the Hypertensive Effect of Angiotensin II in Rats

Canadian Journal of Cardiology

Volumn 30, Issue 12, 2014, Pages 1700-1705

  Ufnal, Marcin ^a   Jazwiec, Radoslaw ^b   Dadlez, Michal ^b   Drapala, Adrian ^a   Sikora, Mariusz ^a   Skrzypecki, Janusz ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b INSTITUTE OF BIOCHEMISTRY AND BIOPHYSICS   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; TRIMETHYLAMINE OXIDE; METHYLAMINE; OXIDIZING AGENT; TRIMETHYLOXAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; BLOOD LEVEL; BODY WEIGHT; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; HEART RATE; HEMODYNAMICS; HYPERTENSION; LIQUID CHROMATOGRAPHY; MOTOR ACTIVITY; NONHUMAN; QUADRUPOLE MASS SPECTROMETRY; RAT; SYSTOLIC BLOOD PRESSURE; ANIMAL; BLOOD PRESSURE; DISEASE MODEL; DRUG EFFECTS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; METABOLISM; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISEASE MODELS, ANIMAL; HYPERTENSION; MALE; METHYLAMINES; OXIDANTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84919718375     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2014.09.010     Document Type: Article

References (24)

1. Wang Z., Klipfell E., Bennett B.J., et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 2011, 472:57-63.
2. Tang W.H., Wang Z., Levison B.S., et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. NEngl J Med 2013, 368:1575-1584.
3. Koeth R.A., Wang Z., Levison B.S., et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med 2013, 19:576-585.
4. al-Waiz M., Mikov M., Mitchell S.C., Smith R.L. The exogenous origin of trimethylamine in the mouse. Metabolism 1992, 41:135-136.
5. Humbert J.A., Hammond K.B., Hathaway W.E. Trimethylaminuria: the fish-odour syndrome. Lancet 1970, 2:770-771.
6. Yancey P.H., Blake W.R., Conley J. Unusual organic osmolytes in deep-sea animals: Adaptations to hydrostatic pressure and other perturbants. Comp Biochem Physiol A Mol Integr Physiol 2002, 133:667-676.
7. American Heart Association Nutrition Committee, Lichtenstein A.H., Appel L.J., Brands M., et al. Diet and lifestyle recommendations revision 2006: A scientific statement from the American Heart Association Nutrition Committee. Circulation 2006, 114:82-96.
8. Ferrario C.M. Role of angiotensin II in cardiovascular disease therapeutic implications of more than a century of research. JRenin Angiotensin Aldosterone Syst 2006, 7:3-14.
9. Bain M.A., Faull R., Fornasini G., Milne R.W., Evans A.M. Accumulation of trimethylamine and trimethylamine-N-oxide in end-stage renal disease patients undergoing haemodialysis. Nephrol Dial Transplant 2006, 21:1300-1304.
10. Sarnak M.J., Levey A.S., Schoolwerth A.C., et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003, 28:2154-2169.
11. Chao C.K., Zeisel S.H. Formation of trimethylamine from dietary choline by Streptococcus sanguis I, which colonizes the mouth. JNutr Biochem 1990, 1:89-97.
12. Zeisel S.H., daCosta K.A., Youssef M., Hensey S. Conversion of dietary choline to trimethylamine and dimethylamine in rats: dose-response relationship. JNutr 1989, 119:800-804.
13. Huang B.S., Ahmadi S., Ahmad M., White R.A., Leenen F.H. Central neuronal activation and pressor responses induced by circulating Ang II: Role of the brain aldosterone-"ouabain" pathway. Am J Physiol 2010, 299:H422-H430.
14. Sikora M., Drapala A., Ufnal M. Exogenous hydrogen sulfide causes different hemodynamic effects in normotensive and hypertensive rats via neurogenic mechanisms. Pharmacol Rep 2014, 66:751-758.
15. Phelan E.L., Eryetishir I., Smirk F.H. Observations on the responses of rats with spontaneous hypertension and control rats to pressor drugs and to hexamethonium. Circ Res 1962, 10:817-824.
16. Toal C.B., Leenen F.H. Blood pressure responsiveness during the development of hypertension in the conscious spontaneously hypertensive rat. Can J Physiol Pharmacol 1985, 63:1258-1262.
17. King A.J., Fink G.D. Chronic low-dose angiotensin II infusion increases venomotor tone by neurogenic mechanisms. Hypertension 2006, 48:927-933.
18. Koba S., Watanabe R., Kano N., Watanabe T. Oxidative stress exaggerates skeletal muscle contraction-evoked reflex sympathoexcitation in rats with hypertension induced by angiotensin II. Am J Physiol Heart Circ Physiol 2013, 304:H142-H153.
19. Pelaez L.I., Manriquez M.C., Nath K.A., Romero J.C., Juncos L.A. Low-dose angiotensin II enhances pressor responses without causing sustained hypertension. Hypertension 2003, 42:798-801.
20. Ufnal M., Skrzypecki J. Blood borne hormones in a cross-talk between peripheral and brain mechanisms regulating blood pressure, the role of circumventricular organs. Neuropeptides 2014, 48:65-73.
21. Li Q., Dale W.E., Hasser E.M., Blaine E.H. Acute and chronic angiotensin hypertension: neural and nonneural components, time course, and dose dependency. Am J Physiol 1996, 271:R200-R207.
22. Yancey P.H. Organic osmolytes as compatible, metabolic and counteracting cytoprotectants in high osmolarity and other stresses. JExp Biol 2005, 208:2819-2830.
23. Street T.O., Bolen D.W., Rose G.D. Amolecular mechanism for osmolyte-induced protein stability. Proc Natl Acad Sci U S A 2006, 103:13997-14002.
24. Mondal J., Stirnemann G., Berne B.J. When does trimethylamine N-oxide fold a polymer chain and urea unfold it?. JPhys Chem B 2013, 117:8723-8732.